Attached files
| file | filename |
|---|---|
| 10-K - Statera Biopharma, Inc. | v177770_10k.htm |
| EX-3.1 - Statera Biopharma, Inc. | v177770_ex3-1.htm |
| EX-32.1 - Statera Biopharma, Inc. | v177770_ex32-1.htm |
| EX-31.2 - Statera Biopharma, Inc. | v177770_ex31-2.htm |
| EX-31.1 - Statera Biopharma, Inc. | v177770_ex31-1.htm |
Exhibit
23.1
Consent
of Independent Registered Public Accounting Firm
The Board
of Directors and Stockholders of
Cleveland
BioLabs, Inc.:
We
consent to the use in the Form 10-K of Cleveland BioLabs, Inc. (the “Company”)
for the fiscal year ended December 31, 2009 and the incorporation by reference
in the registration statement on Form S-8 (No. 333-140687) and the registration
statement on Form S-3 (No. 333-160648) of the Company of our report dated March
15, 2010, with respect to the balance sheets of Cleveland BioLabs, Inc. as of
December 31, 2009 and 2008, and the related statements of operations,
stockholders’ equity, and cash flows for each of the years in the three-year
period ending December 31, 2009, which report appears in the December 31, 2009
annual report on Form 10-K of the Company.
/s/
Meaden & Moore, Ltd.
Cleveland,
Ohio
March 18,
2010